Skip to content

Comparative effect of a mouthwash formulated with Spirulina platensis and Chlorhexidine on chronic pariodontitis in patients with cardiovascular disease: a Clinical trials pilot study

Comparative effect of a mouthwash formulated with Spirulina platensis and Chlorhexidine on chronic pariodontitis in patients with cardiovascular disease:

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202206703009274
Enrollment
54
Registered
2022-06-15
Start date
2021-03-28
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Health

Interventions

mouthwash formulated with Spirulina platensis
Chlorhexidine

Sponsors

PIEME CONSTANT ANATOLE
Lead Sponsor
Alexia Adorance JOTSA
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Adult patients (18 years and older), - men or women with: (1) cardiovascular disease; (2) superficial chronic periodontal inflammation: = 2 inter proximal sites with a loss of attachment = 3mm or =2 inter proximal sites with a pocket depth = 4mm (not on the same tooth) or a single site with a depth of pocket = 5mm (CDC-AAP definition of periodontitis); (3) at least 10 teeth in the oral cavity; (4) -All patients gave written informed consent.

Exclusion criteria

Exclusion criteria: - Patients lost to follow-up for 7 days; those who have withdrawn their informed consent; -Patients with cardiovascular diseases (CVD) but with moderate / severe chronic periodontitis; patients with CVD at risk of endocarditis: valve disease, valve prosthesis, interventricular communication, persistent aortic duct; patients taking antibiotics, anti-inflammatories, tobacco; or having an allergy to algae; patients using toothpaste or any other medicament with periodontal action including toothpaste based on sodium bicarbonate; and pregnant women.

Design outcomes

Primary

MeasureTime frame
The primary endpoint was the change in periodontal indices

Secondary

MeasureTime frame
The secondary endpoints were the change in the level of salivary biochemical markers , pH, Malondialdehyde, Total Antioxidant Capacity

Countries

Cameroon

Contacts

Public ContactArnaud CHOUPO

Faculty of Medicine and Biomedical Sciences University of Yaounde I

arnaudchoupo@yahoo.fr+237695093971

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026